Skip to main content
Signal8

Gault Laura

SEC insider (Form 3/4/5 filer). CIK 0001951944. Chief Medical Officer at Sage Therapeutics, Inc. (SAGE). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 13, 2025. Located in CAMBRIDGE, MA.

Companies Gault Laura has filed insider reports for

  • Sage Therapeutics, Inc. (SAGE): Officer, Chief Medical Officer
Gault Laura profile photo

Gault Laura

CIK: 0001951944

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Sage Therapeutics, Inc. logo
SAGE

Sage Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Feb 13, 2025
    Tax Payment
    Direct
    685 shares at avg. $7.18$5K
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Jan 16, 2025
    Award
    Direct
    24K shares-

1-2 of 2